Clinical and Molecular Determinants of Neoadjuvant Treatment Response in Breast Cancer: A Systematic Review
Vol. 6 No. 2 (2024), Systematic Review
Vol. 6 No. 2 (2024)

Clinical and Molecular Determinants of Neoadjuvant Treatment Response in Breast Cancer: A Systematic Review

Systematic Review
https://doi.org/10.36557/2674-8169.2024v6n2p1815-1822
Published 2024-02-20
José Lucas Moura Vasconcelos
UniFG Guanambi
Anne Louyse Gomes Souza
Universidade Tiradentes - UNIT
https://orcid.org/0009-0009-5974-3144
Braz Martins Neto
Universidade de Cuiabá - UNIC
https://orcid.org/0000-0002-3986-3781
Camilla Barreto Passos
Universidade Tiradentes - UNIT
https://orcid.org/0009-0003-2641-4578
Carine Cecconello
Unochapecó
https://orcid.org/0000-0002-7604-4283
Célio Silva Filho
FACULDADE DAS AMÉRICAS - FAM
https://orcid.org/0009-0006-5837-1180
Eugênio Alencar Muniz Filho
Faculdade Pernambucana de Saúde - FPS
https://orcid.org/0009-0009-3341-1395
Julia Maria Prestes Capatto
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0003-8055-7086
Júlia Terra Suzano
Centro Universitário Municipal de Franca - UNIFACEF
https://orcid.org/0009-0009-9136-3723
Karen Simone Fizinus Rodrigues
Universidade Paranaense - UNIPAR
https://orcid.org/0009-0007-2502-7989
Karolayne Skiba Lazzari
Universidade Paranaense - UNIPAR
https://orcid.org/0009-0006-6356-1966
Layannara Nascimento Santos
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0006-2935-5931
Luiz Gabriel Negro Vaz Seffair
Universidade Nilton Lins
https://orcid.org/0009-0008-7236-8134
Marcela Vilela de Lima
Faculdade de Medicina Municipal de Franca
https://orcid.org/0009-0006-3447-912X
Menderson Augusto Gadelha Cavalcante
Universidade Nilton Lins
https://orcid.org/0009-0009-8620-6643
Monique Evelyn Alves de Queiroz
Universidade Metropolitana da Amazônia - UNIFAMAZ
https://orcid.org/0009-0001-0373-8479
Nara Lis Freire Benigno
Faculdade de Medicina de Olinda - FMO
https://orcid.org/0009-0007-8207-3658
Priscila Coti Lewin
Universidade Anhembi Morumbi - UAM
https://orcid.org/0009-0002-0517-9516
Raphaela Guimarães Fiel
Universidade Tiradentes - UNIT
https://orcid.org/0009-0008-0855-7344
Renan Brezinski Coradin
Universidade Paranaense - UNIPAR
https://orcid.org/0009-0000-6437-0623
Roberta Calumby Barretto de Macedo
Universidade Tiradentes - UNIT
https://orcid.org/0009-0004-4517-3076
Roberta Rodrigues de Lima
Faminas Muriaé
https://orcid.org/0009-0001-9490-1509
PDF (Português (Brasil))

Keywords

breast cancer
neoadjuvant treatment

How to Cite

Vasconcelos, J. L. M., Souza, A. L. G., Neto , B. M., Passos, C. B., Cecconello , C., Filho , C. S., Filho, E. A. M., Capatto, J. M. P., Suzano , J. T., Rodrigues, K. S. F., Lazzari, K. S., Santos , L. N., Seffair , L. G. N. V., Lima , M. V. de, Cavalcante, M. A. G., Queiroz , M. E. A. de, Benigno , N. L. F., Lewin, P. C., Fiel, R. G., Coradin , R. B., Macedo, R. C. B. de, & Lima , R. R. de. (2024). Clinical and Molecular Determinants of Neoadjuvant Treatment Response in Breast Cancer: A Systematic Review. Brazilian Journal of Implantology and Health Sciences, 6(2), 1815–1822. https://doi.org/10.36557/2674-8169.2024v6n2p1815-1822
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

This article presents a systematic review of the clinical and molecular determinants of response to neoadjuvant treatment in patients with breast cancer. Searches were conducted in scientific databases to identify relevant studies investigating factors associated with response to neoadjuvant treatment. The results highlighted the importance of tumor molecular subtype, patient clinical characteristics, and biomarker expression in predicting treatment response. Understanding these determinants can provide valuable insights for clinical practice and guide future research on breast cancer management.

https://doi.org/10.36557/2674-8169.2024v6n2p1815-1822
PDF (Português (Brasil))

References

Cortazar, P., Zhang, L., Untch, M., et al. (2014). Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet, 384(9938), 164-172.

Nichols, H. B., Schoemaker, M. J., Wright, L. B., et al. (2018). Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncology, 4(6), e181771.

Odedina, F. T., Bray, F., Ferlay, J., et al. (2019). Breast Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69(6), 438-451.

Sung, H., Ferlay, J., Siegel, R. L., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 José Lucas Moura Vasconcelos, Anne Louyse Gomes Souza, Braz Martins Neto , Camilla Barreto Passos, Carine Cecconello , Célio Silva Filho , Eugênio Alencar Muniz Filho, Julia Maria Prestes Capatto, Júlia Terra Suzano , Karen Simone Fizinus Rodrigues, Karolayne Skiba Lazzari, Layannara Nascimento Santos , Luiz Gabriel Negro Vaz Seffair , Marcela Vilela de Lima , Menderson Augusto Gadelha Cavalcante, Monique Evelyn Alves de Queiroz , Nara Lis Freire Benigno , Priscila Coti Lewin, Raphaela Guimarães Fiel, Renan Brezinski Coradin , Roberta Calumby Barretto de Macedo, Roberta Rodrigues de Lima